サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1480366

2033年までの免疫診断の世界市場機会と戦略

Immunodiagnostics Global Market Opportunities And Strategies To 2033

出版日
ページ情報
英文 296 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
2033年までの免疫診断の世界市場機会と戦略
出版日: 2024年05月16日
発行: The Business Research Company
ページ情報: 英文 296 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の免疫診断市場は2018年に146億4,640万米ドルと評価され、2023年までCAGR7.0％以上で成長しました。

医療支出の増加

医療支出の増加は、実績期間に免疫診断市場の拡大を牽引しました。医療支出は、イノベーションを推進し、先端技術へのアクセスを向上させるために不可欠です。医療予算が増加するにつれて、疾病の検出とモニタリングにおいて極めて重要な役割を果たす免疫診断を含む高度診断技術に対する需要が急増しました。このような支出の増加により、医療施設は最新鋭の機器や革新的な診断ソリューションに投資できるようになり、市場成長の原動力となりました。米国を拠点とし、メディケア＆メディケイドを含む米国の主要医療プログラムを管理する連邦機関であるメディケア＆メディケイドサービスセンターによると、米国の医療支出は2020年に9.7％増加し、4兆1,000億米ドル、1人当たり1万2,530米ドルに達します。国内総生産（GDP）に占める医療費の割合は、英国では2020年に19.7％、2,690億ポンド（3,544億5,000万米ドル）となり、名目では2019年の支出から20％増加しました。したがって、医療支出の増加は免疫診断市場の成長を促進しました。

目次

第1章 エグゼクティブサマリー

  • 免疫診断-市場の魅力とマクロ経済情勢

第2章 目次

第3章 表一覧

第4章 図一覧

第5章 レポート構成

第6章 市場の特徴

  • 一般的な市場の定義
  • 概要
  • 免疫診断市場定義とセグメンテーション
  • 製品別市場セグメンテーション
    • 試薬と消耗品
    • 機器
    • ソフトウェアとサービス
  • 市場セグメンテーション：技術別
    • 酵素免疫測定法
    • 化学発光免疫測定法
    • 蛍光免疫測定
    • 放射免疫測定
    • 迅速試験
    • その他
  • 市場セグメンテーション：用途別
    • 感染症
    • 腫瘍学と内分泌学
    • 骨とミネラルの病気
    • 自己免疫疾患
    • 心臓バイオマーカー
    • 肝炎とレトロウイルス試験
    • その他
  • 市場セグメンテーション：エンドユーザー別
    • 病院
    • クリニック
    • 診断ラボ
    • 学術研究機関
    • その他

第7章 主要な市場動向

  • 迅速な結果を提供するポイントオブケア免疫診断の採用
  • DNA増幅技術を用いた免疫測定感度の向上
  • 市場参入企業間の戦略的パートナーシップ

第8章 免疫診断市場：マクロ経済シナリオ

  • COVID-19の影響：免疫診断市場
  • ウクライナ戦争の影響：免疫診断市場
  • 高インフレの影響：免疫診断市場

第9章 世界の市場規模と成長

  • 市場規模
  • 市場成長実績、2018～2023年
    • 市場促進要因、2018～2023年
    • 市場抑制要因、2018～2023年
  • 市場成長予測、2023～2028年、2033年
    • 市場促進要因、2023～2028年
    • 市場抑制要因、2023～2028年

第10章 世界の免疫診断市場：セグメンテーション

  • 世界の免疫診断市場：製品別、実績と予測、2018～2023年、2028年、2033年
  • 世界の免疫診断市場：用途別、実績と予測、2018～2023年、2028年、2033年
  • 世界の免疫診断市場：エンドユーザー別、実績と予測、2018～2023年、2028年、2033年
  • 世界の免疫診断市場：技術別、実績と予測、2018～2023年、2028年、2033年

第11章 免疫診断市場：地域・国別分析

  • 世界の免疫診断市場：地域別、実績と予測、2018～2023年、2028年、2033年
  • 世界の免疫診断市場：国別、実績と予測、2018～2023年、2028年、2033年

第12章 アジア太平洋市場

第13章 西欧市場

第14章 東欧市場

第15章 北米市場

第16章 南米市場

第17章 中東市場

第18章 アフリカ市場

第19章 競合情勢と企業プロファイル

  • 企業プロファイル
  • Abbott Laboratories
  • F. Hoffman-La Roche Ltd
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • DiaSorin S.p.A.

第20章 競合ベンチマーキング

第21章 競合ダッシュボード

第22章 主要な合併と買収

  • Novacyt Acquired Yourgene Health
  • Freenome Acquired Oncimmune Ltd.
  • DiaSorin S.p.A Acquired Luminex Corporation
  • Avacta Group plc Acquired Launch Diagnostics Holdings Limited
  • Heska Acquired LightDeck Diagnostics

第23章 機会と戦略

  • 世界の免疫診断市場、2028年：新たな機会を提供する国
  • 世界の免疫診断市場、2028年：新たな機会を提供するセグメント
  • 世界の免疫診断市場、2028年：成長戦略
    • 市場動向別の戦略
    • 競合の戦略

第24章 免疫診断市場：結論と提言

  • 結論
  • 提言
    • 製品
    • 場所
    • 価格
    • プロモーション
    • 人材

第25章 付録

目次
Product Code: o&s1166

Immunodiagnostics refers to a branch of medical diagnostics that utilizes antibodies to detect diseases or conditions. This field relies on the specific interactions between antigens (substances that stimulate an immune response) and antibodies (specific binding proteins produced by immune cells in response to antigens). Immunodiagnostic tests can identify the presence of antigens produced by pathogens such as viruses, bacteria or parasites, as well as detect proteins produced by the body in response to pathogens or pathological changes in organs, tissues and cells in response to disease or injury.

The immunodiagnostics market consists of sales, by entities (organizations, sole traders and partnerships), of immunodiagnostics products and services that utilize the antibodies to detect and measure specific substances through antigen-antibody reactions.

The global immunodiagnostics market was valued at $14,646.4 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 7.0%.

Rise In Healthcare Expenditure

The rise in healthcare expenditure drove the expansion of the immunodiagnostics market during the historic period. Healthcare expenditure is essential for driving innovation and improving access to advanced technologies. As healthcare budgets increased, there was a corresponding surge in demand for advanced diagnostic technologies, including immunodiagnostics, which played a pivotal role in disease detection and monitoring. This increased expenditure allowed healthcare facilities to invest in state-of-the-art equipment and innovative diagnostic solutions, driving market growth. According to the Centers for Medicare & Medicaid Services, a US-based federal agency that administers the nation's major healthcare programs including Medicare and Medicaid, health spending in the USA grew by 9.7% in 2020, reaching $4.1 trillion or $12,530 per person. As a share of the nation's Gross Domestic Product, health spending accounted for 19.7% of GDP in the UK in 2020, which is £269 billion ($354.45 billion), a nominal-terms increase of 20% on spending in 2019. Therefore, the rise in healthcare expenditure propelled the growth of the immunodiagnostics market.

Increasing Immunoassay Sensitivity Using DNA Amplification Technology

Companies operating in immunodiagnostics are increasing immunoassay sensitivity using DNA amplification technology. This approach involves amplifying target DNA sequences associated with specific biomarkers, thereby increasing the detectability of analytes in biological samples. By integrating DNA amplification techniques such as polymerase chain reaction (PCR), into immunoassay platforms, companies can achieve greater sensitivity and accuracy in detecting low-concentration analytes. For instance, in May 2021, Cavidi, a Sweden-based pharmaceutical and diagnostic company, introduced a groundbreaking platform technology called Exazym, signal generating technology to bring ultra-sensitive detection-levels to conventional immunodiagnostic assays. This innovative technology offers a novel signal amplification method known as Binding Oligo Ladder Detection (BOLD), which significantly enhances immunoassay signal amplification by up to 100 times.

The global immunodiagnostics market is fairly fragmented, with a large number of players operating in the market. The top ten competitors in the market made up to 23.25% of the total market in 2022.

Immunodiagnostics Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global immunodiagnostics market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for immunodiagnostics? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The immunodiagnostics market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider immunodiagnostics market; and compares it with other markets.

The report covers the following chapters

  • Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by product, by technology, by application and by end-user.
  • Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the immunodiagnostics market.
  • Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional And Country Analysis - Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
  • Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by product, by technology, by application and by end-user in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
  • Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Competitive Benchmarking - Briefs on the financials comparison between major players in the market.
  • Competitive Dashboard - Briefs on competitive dashboard of major players.
  • Key Mergers And Acquisitions - Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
  • Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations- This section includes recommendations for immunodiagnostics providers in terms of product/service offerings geographic expansion, marketing strategies and target groups next five years.
  • Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

  • 1) By Product: Reagents And Consumables; Instruments; Software And Services
  • 2) By Technology: Enzyme-Linked Immunosorbent Assay; Chemiluminescence Immunoassay; Fluorescent Immunoassay; Radioimmunoassay; Rapid Test; Other Technologies
  • 3) By Application: Infectious Diseases; Oncology And Endocrinology; Bone And Mineral Diseases; Autoimmunity Disorders; Cardiac Biomarkers; Hepatitis And Retrovirus Testing; Other Applications
  • 4) By End-User: Hospitals; Clinics; Diagnostic Laboratories; Academic And Research Institutes; Other End-Users
  • Companies Mentioned: Abbott Laboratories;F. Hoffmann-La Roche Ltd;Thermo Fisher Scientific Inc.; Danaher Corporation; DiaSorin S.p.A.
  • Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; Italy; Spain; UK; Russia
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time-series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; immunodiagnostics indicators comparison.
  • Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

  • 1.1 Immunodiagnostics - Market Attractiveness And Macro Economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

  • 6.1 General Market Definition
  • 6.2 Summary
  • 6.3 Immunodiagnostics Market Definition And Segmentations
  • 6.4 Market Segmentation By Product
    • 6.4.1 Reagents And Consumables
    • 6.4.2 Instruments
    • 6.4.3 Software And Services
  • 6.5 Market Segmentation By Technology
    • 6.5.1 Enzyme-Linked Immunosorbent Assay
    • 6.5.2 Chemiluminescence Immunoassay
    • 6.5.3 Fluorescent Immunoassay
    • 6.5.4 Radioimmunoassay
    • 6.5.5 Rapid Test
    • 6.5.6 Other Technologies
  • 6.6 Market Segmentation By Application
    • 6.6.1 Infectious Diseases
    • 6.6.2 Oncology And Endocrinology
    • 6.6.3 Bone And Mineral Diseases
    • 6.6.4 Autoimmune Disorders
    • 6.6.5 Cardiac Biomarkers
    • 6.6.6 Hepatitis And Retrovirus Testing
    • 6.6.7 Other Applications
  • 6.7 Market Segmentation By End-User
    • 6.7.1 Hospitals
    • 6.7.2 Clinics
    • 6.7.3 Diagnostic Laboratories
    • 6.7.4 Academic And Research Institutes
    • 6.7.5 Other End Users

7 Major Market Trends

  • 7.1 Introduction Of Point-Of-Care Immunodiagnostics To Provide Rapid Results
  • 7.2 Increasing Immunoassay Sensitivity Using DNA Amplification Technology
  • 7.3 Strategic Partnership Among Market Players

8 Immunodiagnostics Market - Macro Economic Scenario

  • 8.1 COVID-19 Impact On The Immunodiagnostics Market
  • 8.2 Impact Of The War In Ukraine On The Immunodiagnostics Market
  • 8.3 Impact Of High Inflation On The Immunodiagnostics Market

9 Global Market Size and Growth

  • 9.1 Market Size
  • 9.2 Historic Market Growth, 2018 - 2023, Value ($ Million)
    • 9.2.1 Market Drivers 2018 - 2023
    • 9.2.2 Market Restraints 2018 - 2023
  • 9.3 Forecast Market Growth, 2023 - 2028, 2033F Value ($ Million)
    • 9.3.1 Market Drivers 2023 - 2028
    • 9.3.2 Market Restraints 2023 - 2028

10 Global Immunodiagnostics Market Segmentation

  • 10.1 Global Immunodiagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.2 Global Immunodiagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.3 Global Immunodiagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.4 Global Immunodiagnostics Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

11 Immunodiagnostics Market, Regional and Country Analysis

  • 11.1 Global Immunodiagnostics Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 11.2 Global Immunodiagnostics Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

12 Asia-Pacific Market

  • 12.1 Summary
  • 12.2 Market Overview
    • 12.2.1 Region Information
    • 12.2.2 Market Information
    • 12.2.3 Background Information
    • 12.2.4 Government Initiatives
    • 12.2.5 Regulations
    • 12.2.6 Regulatory Bodies
    • 12.2.7 Major Associations
    • 12.2.8 Taxes Levied
    • 12.2.9 Corporate Tax Structure
    • 12.2.10 Investments
    • 12.2.11 Major Companies
  • 12.3 Asia-Pacific Immunodiagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.4 Asia-Pacific Immunodiagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.5 Asia-Pacific Immunodiagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.6 Asia-Pacific Immunodiagnostics Market: Country Analysis
  • 12.7 China Market
  • 12.8 Summary
  • 12.9 Market Overview
    • 12.9.1 Country Information
    • 12.9.2 Market Information
    • 12.9.3 Background Information
    • 12.9.4 Government Initiatives
    • 12.9.5 Taxes Levied
    • 12.9.6 Regulations
    • 12.9.7 Regulatory Bodies
    • 12.9.8 Major Associations
    • 12.9.9 Corporate Tax Structure
    • 12.9.10 Investments
    • 12.9.11 Major Companies
  • 12.10 China Immunodiagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.11 China Immunodiagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.12 China Immunodiagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.13 India Market
  • 12.14 India Immunodiagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.15 India Immunodiagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.16 India Immunodiagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.17 Japan Market
  • 12.18 Japan Immunodiagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.19 Japan Immunodiagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.20 Japan Immunodiagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.21 Australia Market
  • 12.22 Australia Immunodiagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.23 Australia Immunodiagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.24 Australia Immunodiagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.25 Indonesia Market
  • 12.26 Indonesia Immunodiagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.27 Indonesia Immunodiagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.28 Indonesia Immunodiagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.29 South Korea Market
  • 12.30 South Korea Immunodiagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.31 South Korea Immunodiagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.32 South Korea Immunodiagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

13 Western Europe Market

  • 13.1 Summary
  • 13.2 Market Overview
    • 13.2.1 Region Information
    • 13.2.2 Market Information
    • 13.2.3 Background Information
    • 13.2.4 Government Initiatives
    • 13.2.5 Regulations
    • 13.2.6 Regulatory Bodies
    • 13.2.7 Major Associations
    • 13.2.8 Taxes Levied
    • 13.2.9 Corporate tax structure
    • 13.2.10 Investments
    • 13.2.11 Major Companies
  • 13.3 Western Europe Immunodiagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.4 Western Europe Immunodiagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.5 Western Europe Immunodiagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.6 Western Europe Immunodiagnostics Market: Country Analysis
  • 13.7 UK Market
  • 13.8 UK Immunodiagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.9 UK Immunodiagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.10 UK Immunodiagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.11 Germany Market
  • 13.12 Germany Immunodiagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.13 Germany Immunodiagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.14 Germany Immunodiagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.15 France Market
  • 13.16 France Immunodiagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.17 France Immunodiagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.18 France Immunodiagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.19 Italy Market
  • 13.20 Italy Immunodiagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.21 Italy Immunodiagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.22 Italy Immunodiagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.23 Spain Market
  • 13.24 Spain Immunodiagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.25 Spain Immunodiagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.26 Spain Immunodiagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

14 Eastern Europe Market

  • 14.1 Summary
  • 14.2 Market Overview
    • 14.2.1 Region Information
    • 14.2.2 Market Information
    • 14.2.3 Background Information
    • 14.2.4 Government Initiatives
    • 14.2.5 Regulations
    • 14.2.6 Regulatory Bodies
    • 14.2.7 Major Associations
    • 14.2.8 Taxes Levied
    • 14.2.9 Corporate Tax Structure
    • 14.2.10 Major Companies
  • 14.3 Eastern Europe Immunodiagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.4 Eastern Europe Immunodiagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.5 Eastern Europe Immunodiagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.6 Eastern Europe Immunodiagnostics Market: Country Analysis
  • 14.7 Russia Market
  • 14.8 Russia Immunodiagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.9 Russia Immunodiagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.10 Russia Immunodiagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

15 North America Market

  • 15.1 Summary
  • 15.2 Market Overview
    • 15.2.1 Region Information
    • 15.2.2 Market Information
    • 15.2.3 Background Information
    • 15.2.4 Government Initiatives
    • 15.2.5 Regulations
    • 15.2.6 Regulatory Bodies
    • 15.2.7 Major Associations
    • 15.2.8 Taxes Levied
    • 15.2.9 Corporate Tax Structure
    • 15.2.10 Investments
    • 15.2.11 Major Companies
  • 15.3 North America Immunodiagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.4 North America Immunodiagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.5 North America Immunodiagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.6 North America Immunodiagnostics Market: Country Analysis
  • 15.7 USA Market
  • 15.8 Summary
  • 15.9 Market Overview
    • 15.9.1 Country Information
    • 15.9.2 Market Information
    • 15.9.3 Background Information
    • 15.9.4 Government Initiatives
    • 15.9.5 Regulations
    • 15.9.6 Regulatory Bodies
    • 15.9.7 Major Associations
    • 15.9.8 Taxes Levied
    • 15.9.9 Corporate Tax Structure
    • 15.9.10 Investments
    • 15.9.11 Major Companies
  • 15.10 USA Immunodiagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.11 USA Immunodiagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.12 USA Immunodiagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.13 Canada Market
  • 15.14 Canada Immunodiagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.15 Canada Immunodiagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.16 Canada Immunodiagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

16 South America Market

  • 16.1 Summary
  • 16.2 Market Overview
    • 16.2.1 Region Information
    • 16.2.2 Market Information
    • 16.2.3 Background Information
    • 16.2.4 Government Initiatives
    • 16.2.5 Regulations
    • 16.2.6 Regulatory Bodies
    • 16.2.7 Major Associations
    • 16.2.8 Taxes Levied
    • 16.2.9 Corporate Tax Structure
    • 16.2.10 Investment
    • 16.2.11 Major Companies
  • 16.3 South America Immunodiagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.4 South America Immunodiagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.5 South America Immunodiagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.6 South America Immunodiagnostics Market: Country Analysis
  • 16.7 Brazil Market
  • 16.8 Brazil Immunodiagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.9 Brazil Immunodiagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.10 Brazil Immunodiagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

17 Middle East Market

  • 17.1 Summary
  • 17.2 Market Overview
    • 17.2.1 Region Information
    • 17.2.2 Market Information
    • 17.2.3 Background Information
    • 17.2.4 Government Initiatives
    • 17.2.5 Regulations
    • 17.2.6 Regulatory Bodies
    • 17.2.7 Major Associations
    • 17.2.8 Taxes Levied
    • 17.2.9 Corporate Tax Structure
    • 17.2.10 Investments
    • 17.2.11 Major Companies
  • 17.3 Middle East Immunodiagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.4 Middle East Immunodiagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.5 Middle East Immunodiagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

18 Africa Market

  • 18.1 Summary
  • 18.2 Market Overview
    • 18.2.1 Region Information
    • 18.2.2 Market Information
    • 18.2.3 Background Information
    • 18.2.4 Government Initiatives
    • 18.2.5 Regulations
    • 18.2.6 Regulatory Bodies
    • 18.2.7 Major Associations
    • 18.2.8 Taxes Levied
    • 18.2.9 Corporate Tax Structure
    • 18.2.10 Investments
    • 18.2.11 Major Companies
  • 18.3 Africa Immunodiagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.4 Africa Immunodiagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.5 Africa Immunodiagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

19 Competitive Landscape And Company Profiles

  • 19.1 Company Profiles
  • 19.2 Abbott Laboratories
    • 19.2.1 Company Overview
    • 19.2.2 Products And Services
    • 19.2.3 Business Strategy
    • 19.2.4 Financial Overview
  • 19.3 F. Hoffman-La Roche Ltd
    • 19.3.1 Company Overview
    • 19.3.2 Products And Services
    • 19.3.3 Business Strategy
    • 19.3.4 Financial Overview
  • 19.4 Thermo Fisher Scientific Inc.
    • 19.4.1 Company Overview
    • 19.4.2 Products And Services
    • 19.4.3 Business Strategy
    • 19.4.4 Financial Overview
  • 19.5 Danaher Corporation
    • 19.5.1 Company Overview
    • 19.5.2 Products And Services
    • 19.5.3 Business Strategy
    • 19.5.4 Financial Overview
  • 19.6 DiaSorin S.p.A.
    • 19.6.1 Company Overview
    • 19.6.2 Products And Services
    • 19.6.3 Business Strategy
    • 19.6.4 Financial Overview

20 Competitive Benchmarking

21 Competitive Dashboard

22 Key Mergers And Acquisitions

  • 22.1 Novacyt Acquired Yourgene Health
  • 22.2 Freenome Acquired Oncimmune Ltd.
  • 22.3 DiaSorin S.p.A Acquired Luminex Corporation
  • 22.4 Avacta Group plc Acquired Launch Diagnostics Holdings Limited
  • 22.5 Heska Acquired LightDeck Diagnostics

23 Opportunities And Strategies

  • 23.1 Global Immunodiagnostics Market In 2028 - Countries Offering Most New Opportunities
  • 23.2 Global Immunodiagnostics Market In 2028 - Segments Offering Most New Opportunities
  • 23.3 Global Immunodiagnostics Market In 2028 - Growth Strategies
    • 23.3.1 Market Trend Based Strategies
    • 23.3.2 Competitor Strategies

24 Immunodiagnostics Market, Conclusions And Recommendations

  • 24.1 Conclusions
  • 24.2 Recommendations
    • 24.2.1 Product
    • 24.2.2 Place
    • 24.2.3 Price
    • 24.2.4 Promotion
    • 24.2.5 People

25 Appendix

  • 25.1 Geographies Covered
  • 25.2 Market Data Sources
  • 25.3 Research Methodology
  • 25.4 Currencies
  • 25.5 The Business Research Company
  • 25.6 Copyright and Disclaimer